바이오인

BioMarket Trends: Orphan Drug Arena Driven by Biologics

 

Entry of Biogenerics Will Radically Alter Market that Is Mainstay of Some Biotech Firms

Syamala Ariyanchira, Ph.D.

 

An orphan drug can be defined as a product that treats a rare disease, although different countries have slightly different definitions. For example, the FDA defines a rare disease as a disease with an incidence of less than 1:5,000 of the general population, while the European Union defines it as a disease with a prevalence of 5:10,000.